Back
National Bank of Canada Vs. AnaptysBio, Inc. Industry Stock Comparison
Buy
67
NTIOF
National Bank of Canada
Last Price:
$133.26
Seasonality Move:
4.7%
Sell
47
ANAB
AnaptysBio, Inc.
Last Price:
$57.92
Seasonality Move:
5.3%
Buy
67
National Bank of Canada (NTIOF)
is a Buy
Is National Bank of Canada a Buy, Sell or Hold?
-
The current National Bank of Canada [NTIOF] share price is $133.26. The Score for NTIOF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
NTIOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
AnaptysBio, Inc. (ANAB)
is a Sell
Is AnaptysBio, Inc. a Buy, Sell or Hold?
-
The current AnaptysBio, Inc. [ANAB] share price is $57.68. The Score for ANAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ANAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTIOF Stock Price Chart
What is National Bank of Canada's stock price today?
-
The National Bank of Canada share price today is $133.26Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTIOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANAB Stock Price Chart
What is AnaptysBio, Inc.'s stock price today?
-
The AnaptysBio, Inc. share price today is $57.68The current trend is relatively stagnant and ANAB is experiencing slight selling pressure.
NTIOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 54.53 | Buy |
| Chaikin Money Flow: | 3855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (129.31 - 137.65) | Sell |
| Bollinger Bands (100): | (119.21 - 132.57) | Buy |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 46.79 | Sell |
| Chaikin Money Flow: | -120538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.32 - 64.78) | Sell |
| Bollinger Bands (100): | (41.49 - 58.03) | Buy |
NTIOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 130.02 | Buy |
| 20-day SMA: | 131.93 | Buy |
| 50-day SMA: | 129.56 | Buy |
| 200-day SMA: | 116.16 | Buy |
| 8-day EMA: | 130.78 | Buy |
| 20-day EMA: | 131.28 | Buy |
| 50-day EMA: | 129.8 | Buy |
| 200-day EMA: | 117.39 | Buy |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.51 | Sell |
| 20-day SMA: | 61.65 | Sell |
| 50-day SMA: | 55.97 | Buy |
| 200-day SMA: | 37.84 | Buy |
| 8-day EMA: | 58.76 | Sell |
| 20-day EMA: | 59.68 | Sell |
| 50-day EMA: | 56.33 | Buy |
| 200-day EMA: | 41.98 | Buy |
National Bank of Canada Earnings Growth & NTIOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.19 per share, an increase this year of $1.36 per share, and an increase next year of $1.00 per share.
AnaptysBio, Inc. Earnings Growth & ANAB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.13 per share, a decrease this year of $2.63 per share, and an increase next year of $0.54 per share.
National Bank of Canada Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||